14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
Good news for the motor carrier industry … for now. A federal judge has issued a temporary restrain...
Read More >
On December 5, 2019, the National Toxicology Program (NTP) announced that the NTP Technical Report o...
Read More >
The location exception to CEQA’s categorical exemptions does not apply to earthquake and landslide ...
Read More >
In House v. Akorn, Inc. the United States District Court for the Norther District of Illinois Easter...
Read More >
Restrictive covenant matters rarely make it through the appellate courts. This is true for a number ...
Read More >
On June 25, 2020, the Fifth Appellate District decided Honchariw v. County of Stanislaus, holding th...
Read More >